As part of a $70B global pharma leader improving patients’ lives, Roche operates Data and AI at global scale. Facing fragmented investments and high spend with limited benefit, Roche shifted from traditional data management to running Data and AI as a global value portfolio. This session explains the framework used to prioritize and scale AI initiatives, embed Data Mesh and Governance, and link AI investments to business strategy.